SLC2A11 Knockout HEK293 Cell Line
Cat.No.:
EDC08368
Species:
Human
Cell Name:
HEK293
Gene:
SLC2A11
Gene ID:
66035
Size:
1×10⁶ cells
SLC2A11 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08368 |
|---|---|
| Product Name | SLC2A11 Knockout HEK293 Cell Line |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | SLC2A11 |
| NCBI Gene ID | |
| Gene Synonyms | GLUT10|GLUT11 |
| Summary |
This gene belongs to a family of proteins that mediate the transport of sugars across the cell membrane. The encoded protein transports glucose and fructose. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/2~1/4 |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete Culture Medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC2A11 function, SLC2A11 Knockout HEK293 Cell Line or SLC2A11 overexpression HEK293 Cell Line?
The choice depends on whether you are studying SLC2A11 (GLUT11)'s role as a class II fructose-preferring glucose transporter or its tissue-specific functions in skeletal muscle, heart, and kidney. The Knockout line is the standard tool for asking whether GLUT11 is required for cellular hexose transport in non-classical contexts — GLUT11 has substrate selectivity favoring fructose over glucose. Overexpression is useful for testing transport activity in heterologous systems or for studying GLUT11's three reported splice isoforms (GLUT11-A, -B, -C with distinct tissue expression).
For GLUT11 research, the EDITGENE Knockout in HEK293 is a mechanistic platform — HEK293 has been extensively used for GLUT family biochemistry. This product complements the parallel SLC2A11 Knockout in HCT 116 (also available); HEK293 is preferred for biochemistry and structure-function studies given its high transfection efficiency and established protocols. Rescue with wild-type, isoform-specific, or transport-deficient GLUT11 enables comprehensive structure-function analysis.
What are the application scenarios for this model?
Primary applications:
• Fructose vs glucose uptake assays: comparative ³H-fructose and ³H-glucose uptake to characterize GLUT11's reported fructose preference.
• Isoform-specific studies: GLUT11-A (muscle/heart/kidney), GLUT11-B, and GLUT11-C isoforms have distinct tissue expression — rescue with specific isoforms enables functional dissection.
• GLUT family comparison: parallel analysis with other class II GLUTs (GLUT5, GLUT7, GLUT9) for paralog-specific substrate characterization.
• Heterologous expression: biochemical and structure-function studies of GLUT11 in a high-transfection-efficiency background.
EDITGENE recommends this HEK293-based model for biochemical and structure-function studies; the parallel SLC2A11 Knockout in HCT 116 is preferred for cancer biology contexts.
Is this SLC2A11 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. GLUT11 rescue experiments require attention to isoform diversity:
• Construct design: use a codon-modified SLC2A11 sequence with a small C-terminal tag (FLAG, HA). GLUT11 has 12 transmembrane domains — preserve canonical GLUT family architecture.
• Isoform-specific rescue: GLUT11-A (muscle/heart/kidney), GLUT11-B (kidney/adipose), and GLUT11-C (heart/skeletal muscle) have distinct N-termini — choose isoforms based on the experimental question.
• Transport-deficient rescue: substrate-binding pocket mutations enable distinguishing fructose from glucose transport activities.
• Functional readout: rescue should restore fructose and glucose uptake activities measured by radiolabel or LC-MS.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.